4//SEC Filing
Dahlquist Karl S. 4
Accession 0001323885-23-000049
CIK 0001323885other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:03 PM ET
Size
5.0 KB
Accession
0001323885-23-000049
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Dahlquist Karl S.
Chief Legal Officer
Transactions
- Sale
Common Stock
2023-05-01$44.83/sh−4,417$198,014→ 36,319 total
Footnotes (2)
- [F1]These shares were sold pursuant to a 10b5-1 trading plan adopted on February 24, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $44.31 to $45.45 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
AtriCure, Inc.
CIK 0001323885
Entity typeother
Related Parties
1- filerCIK 0001861996
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 4:03 PM ET
- Size
- 5.0 KB